Abstract
As normal constituents of blood serum, the Serum Amyloid A (SAA) proteins are small (104 amino acids in humans) and remarkably well-conserved in mammalian evolution. They are synthesized prominently, but not exclusively, in the liver. Fragments of SAA can associate into insoluble fibrils (called “amyloid”) characteristic of “secondary” amyloid disease in which they can interrupt normal physiology and lead to organ failure. SAA proteins comprise a family of molecules, two members of which (SAA1 and SAA2) are (along with C-reactive protein, CRP) the most prominent members of the acute phase response (APR) during which their serum levels rise dramatically after trauma, infection and other stimuli. Biologic function (s) of SAA are unresolved but features are consistent with a prominent role in primordial host defense (including the APR ). SAA proteins are lipophilic and contribute to high density lipoproteins (HDL) and cholesterol transport. SAA proteins interact with specific receptors and have been implicated in tissue remodeling through metalloproteinases, local tissue changes in atherosclerosis, cancer metastasis, lung inflammation, maternal–fetal health and intestinal physiology. Molecular details of some of these are emerging.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aly H, Hamed Z, Mohsen L et al (2011) Serum amyloid A protein and hypoxic ischemic encephalopathy in the newborn. J Perinatol 31:263–268. https://doi.org/10.1038/jp.2010.130
Atarashi K, Tanoue T, Ando M et al (2015) Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163:367–380
Benson MD, Buxbaum JN, Eisenberg DS et al (2019) Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid 5pp. https://doi.org/10.1080/13506129.2018.1549825
Bozinovski S, Hutchinson A, Thompson M et al (2008) Serum amyloid A is a biomarker of acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:269–278
Bozinovski S, Uddin M, Thompson M et al (2012) Serum amyloid A opposes lipoxin A4 to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci 109:935–940
Brinckerhoff CE, Mitchell TI, Karmilowicz MJ et al (1989) Autocrine induction of collagenase by serum amyloid A-like and B2-microglobulin-like proteins. Science 243:655–657
Burgess EJ, Hoyt LR, Randall MJ et al (2018) Bacterial lipoproteins constitute the TLR-stimulating activity of serum amyloid A. J Immunol 201:2377–2384
Chen ES, Song Z, Willett MH et al (2010) Serum Amyloid A regulates granulomatous inflammation in sarcoidosis through toll-like receptor-2. Am J Respir Crit Care Med 181:360–373
Cheng N, Liang Y, Du X et al (2018) Serum amyloid A promotes LPS clearance and suppresses LPS-induced inflammation and tissue injury. EMBO Rep (e45517):14pp. https://doi.org/10.15252/embr.201745517
Claus S, Meinhardt K, Aumuller T et al (2017) Cellular mechanism of fibrila formation from serum amyloid A1 protein. EMBO Rep 18(8):1352–1366
Cohen AS, Calkins E (1959) Electron microscopic observations on a fibrous component in amyloid of diverse origins. Nature 183:1202–1203
Connolly M, Marelli A, Blades M et al (2010) Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis/SCID mouse chimera model. J Immunol 184:6427–6437
Connolly M, Mullan RH, McCormick J et al (2012) Acute=phase serum amyloid A regulates tumor necrosis factor alpha and matric turnover and preficts disease progression in pastients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum 64(4):1035–1045
De Buck M, Gouwy M, Wang JM et al (2016a) The cytokine-serum amyloid A-Chemokine network. Cytokine Growth Factor Rev 30:55–69
De Buck M, Gouwy M, Wang JM et al (2016b) Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults. Curr Med Chem 23:1725–1755
Hari-Dass R, Shah C, Meyer DJ et al (2005) Serum amyloid A proteins binds to outer membrane protein A of gram-negative bacteria. J Biol Chem 280(19):18562–18567
Ibrahim M, Ramy AR, Abdelhamid A et al (2017) Maternal serum amyloid A level as a novel marker of primary unexplained recurrent early pregnancy loss. Int J Gynecol Obstet 136:298–303
Ivanov II, Atarashi K, Manel N et al (2009) Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139:485–498
King VL, Thompson J, Tannock LR (2011) Serum amyloid A in atherosclerosis. Curr Opin Lipidol 22:302–307
Kisilevsky R, Manley PN (2012) Acute-phase serum amyloid A: perspectives on its physiological and pathological roles. Amyloid 19(1):5–14
Knebel FH, Uno M, Galatro TF, Bellé LP, Oba-Shinjo SM, Marie SKN, Campa A (2017) Serum amyloid A1 is upregulated in human glioblastoma. J Neuro-Oncol 132(3):383–391
Kushner I (1982) The phenomenon of the acute phase response. Ann N Y Acad Sci 39–48
Landskron G, De La Fuente M, Thuwajit P et al (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014:149185. https://doi.org/10.1155/2014/149185
Larson MA, Weber A, Weber AT et al (2005) Differential expression and secretion of bovine serum amyloid A3 (SAA3) by mammary epithelial cells stimulated with prolactin or lipopolysaccharide. Vet Immunol Immunopathol 107:255–264
Lee JW, Stone ML, Porrett PM et al (2019) Hepatocytes direct the formation of a pro-metastatic niche in the liver. Nature 567:249–252
Linke RP, Meinel A, Chalcroft JP et al (2017) Serum amyloid A (SAA) treatment enhances the recovery of aggravated polymicrobial sepsis in mice, whereas blocking SAA's invariant peptide results in early death. Amyloid 24(S1):149–150
Lu J, Yu Y, Zhu I et al (2014) Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis. Proc Natl Acad Sci 111(14):5189–5194
Luhrs T, Ritter C, Adrian M et al (2005) 3D structure of Alzheimer's amyloid-β(1–42) fibrils. Proc Natl Acad Sci USA 102(48):17341–17347
Mack DR, McDonald TL, Larson MA et al (2003) The conserved TFLK motif of mammary-associated Serum Amyloid A3 is responsible for Up-regulation of intestinal MUC3 mucin expression in vitro. Pediatr Res 53(1):137–142
McDonald TL, Larson MA, Mack DR et al (2001) Elevated extrahepatic expression and secretion of mammary-associated serum amyloid A3 (M-SAA3) into colostrum. Vet Immunol Immunopathol 83:203–211
Meeker AK, Sack GH Jr (1998) A fusion protein between serum amyloid A and staphylococcal nuclease—synthesis, purification, and structural studies. Proteins Struct Funct Genet 30:381–387
Mithal LB, Palac HL, Yogev R et al (2017) Cord blood acute phase reactants predict early onset neonatal sepsis in preterm infants. PLoS ONE 12(1):E0168677. https://doi.org/10.1371/journal.pone.0168677
Morrow JF, Stearman RS, Peltzman CG et al (1981) Induction of hepatic synthesis of serum amyloid A protein and actin. Proc Natl Acad Sci USA 78:4718–4722
Moshkovskii SA (2012) Why do cancer cells produce serum amyloid A acute-phase protein? Biochemistry (Moscow) 77(4):339–341
Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with Canakinumab for atherosclerotic disease. N Engl J Med 377(12):1119–1131
Sack GH Jr (2009) Amyloidosis (Chap. 46). In: Stone JH (ed) A clinician's pearls and myths in rheumatology. Springer, Dordrecht, pp 461–466
Sack GH Jr (2018) Serum amyloid A - a review. Mol Med 24:46. https://doi.org/10.1186/s10020-10018-10047-10020
Sack GH Jr (2019) The pathophysiology of amyloid fibril formation. In: Amyloidosis. IntechOpen, London. https://doi.org/10.5772/intechopen.81965
Sack GH Jr, Zink MC (1992) Serum amyloid A (SAA) gene expression in synovial cells in retroviral arthritis. Am J Pathol 141:525–529
Sack GH Jr, Zachara N, Rosenblum N et al (2018) Serum amyloid A1 (SAA1) protein in human colostrum. FEBS OpenBio 8:435–441. https://doi.org/10.1002/2211-5463.12383
Sano T, Huang W, Hall JA et al (2015) An IL-23/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163:381–393
Shah C, Hari-Dass R, Raynes JG (2006) Serum amyloid A is an innate immune opsonin for Gram-negative bacteria. Blood 108:1751–1757
Sipe JD (1999) Revised nomenclature for serum Amyloid A (SAA). Nomenclature committee for the international society of amyloidosis. Part 1. Amyloid 6:67–70
Sun L, Ye RD (2016) Serum amyloid A1: structure, function and gene polymorphism. Gene 583:48–57
Yang Q, Whitin JC, Ling XB et al (2009) Plasma biomarkers in a mouse model of preterm labor. Pediatr Res 66(1):11–16
Ye RD, Sun L (2015) Emerging functions of serum amyloid A in inflammation. J Leukoc Biol 98(6):923–929
Zhou H, Chen M, Zhang G et al (2017) Suppression of lipopolysaccharide-induced inflammatory response by fragments from serum amyloid A. J Immunol 199:1105–1112
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sack, G.H. (2020). Serum Amyloid A (SAA) Proteins. In: Hoeger, U., Harris, J. (eds) Vertebrate and Invertebrate Respiratory Proteins, Lipoproteins and other Body Fluid Proteins. Subcellular Biochemistry, vol 94. Springer, Cham. https://doi.org/10.1007/978-3-030-41769-7_17
Download citation
DOI: https://doi.org/10.1007/978-3-030-41769-7_17
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-41768-0
Online ISBN: 978-3-030-41769-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)